The Recall Desk
ModerateFDA (Devices)·Z-1338-2014·Announced 2014-04-16

LumiQuick Syphilis Test Cards Recalled for Unapproved Distribution

LumiQuick Diagnostics is recalling Syphilis Test Cards because they were shipped to locations without required FDA clearances.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity score when no specific injuries or illnesses are reported in the source text.

Plain-English summary

LumiQuick Diagnostics Inc. is recalling all lots of the Syphilis Test Card Whole Blood (Serum), catalog number 71016. The recall is due to the product being shipped to US locations that do not have approved applications for PMA, IDE, or 510(k) clearance.

The affected products were distributed in the states of California, Florida, New Jersey, Texas, and New York. The recall covers all lots of the product.

Consumers and healthcare providers should stop using the product and contact the manufacturer for further instructions.

The recalled product

Product
Syphilis Test Card Whole Blood(Serum) LumiQuick, Santa Clara, CA 95054

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Catalog number: 71016
  • All lots

Distribution

Distributed in 5 states:

Part of a larger recall action

This product is one of 80 recalled by LumiQuick Diagnostics Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 80 products in this recall →

Same manufacturer · LumiQuick Diagnostics Inc.

See all →